Stomach and duodenum Basic Science Review - PowerPoint PPT Presentation

1 / 62
About This Presentation
Title:

Stomach and duodenum Basic Science Review

Description:

... state, pernicious anemia, adenomatous polyp, previous gastric surgery ... C) Gastric hyperplastic polyps. D) Gastric adenomatous polyps ... – PowerPoint PPT presentation

Number of Views:294
Avg rating:3.0/5.0
Slides: 63
Provided by: donald120
Category:

less

Transcript and Presenter's Notes

Title: Stomach and duodenum Basic Science Review


1
Stomach and duodenumBasic Science Review
  • Donald Baril
  • October 21, 2004

2
Embryology
  • Stomach and duodenum develop from the caudal
    portion of the embryonic foregut
  • Development starts in the 5th week of gestation
  • Rate of growth of the left gastric wall gtright
    gastric wall

3
Anatomy
  • Cardia immediately distal to the GE junction
  • Fundus above the GE junction
  • Body central portion marked distally by the
    angularis incisura
  • Pylorus distal segment

4
(No Transcript)
5
Anatomic relationships
  • Anteriorly left hemidiaphragm, left lobe of the
    liver, anterior portion of the right lobe of the
    liver, parietal surface of the abdominal wall
  • Posteriorly left diaphragm, left adrenal, neck,
    tail, body of the pancreas, aorta and celiac
    trunk
  • Inferiorly transverse colon and its mesentery

6
Blood supply
7
Lymphatic drainage
8
Nervous supply
  • Vagal trunks
  • Left anterior
  • Hepatic branch
  • Anterior gastric wall
  • Right posterior
  • Celiac division
  • Posterior gastric wall

9
Gastric mucosa
  • Lined by simple columnar cells with 3 types of
    gastric glands
  • Cardiac contain mucus glands, undifferentiated
    glands and endocrine glands
  • Oxyntic contain acid-secreting parietal cells
    and chief cells that synthesize pepsinogen
  • Antral contain gastrin-secreting cells

10
(No Transcript)
11
Pepsinogen
  • Synthesized by chief cells
  • Activated by falling pH level
  • Catalyzes hydrolysis of peptide bonds
  • Initiates protein digestion
  • Most important stimuli for secretion is
    stimulation of muscarinic receptors

12
Intrinsic factor
  • Secreted by the parietal cells
  • Necessary for the absorption of vitamin B12 from
    the terminal ileum
  • Secretion stimulated by histamine, acetylcholine,
    and gastrin
  • Atrophy of the parietal cells, characteristic of
    pernicious anemia, results in deficiency of IF

13
Acid secretion
  • Basal acid secretion is 2-5 mEq/hr
  • 3 phases
  • Cephalic mediated by cholinergic stimulation
  • Gastric stimulated by presence of partially
    hydrolyzed food and gastric distension
  • Small peptide fragments and amino acids -gt
    gastrin release
  • Intestinal mediated by secretin, somatostatin,
    peptide YY, and gastric inhibitory peptide

14
(No Transcript)
15
Gastric peristalsis
  • Basic electrical rhythm of 3 cycles/minute
  • Increased contractile activity with the ingestion
    of food
  • Pylorus opens and closes every 2-3/seconds,
    allowing for passage of a small amount of fluid
  • Remaining fluid is propelled retrograde

16
Peptic ulcer disease
  • 300,000 new cases/year in the U.S.
  • 4 million people receiving medical therapy
  • Pathogenic factors
  • Acid secretion increased basal secretion,
    increased meal response, abnormal gastric
    emptying
  • Environmental NSAID use, H. pylori infection,
    cigarette use
  • Mucosal defense decreased bicarbonate
    production, decreased gastric mucosal
    prostaglandin production

17
(No Transcript)
18
Peptic ulcer disease - Pathogenesis
  • Cigarette smoking alters mucosal blood flow,
    decreased mucosal PGE2 production and increases
    acid stimulation
  • NSAIDs systemic suppression of PGE2 production

19
Peptic ulcer disease H. pylori
  • 1886 - ? Relationship between peptic ulcer
    disease and spiral bacteria
  • 1981 - Robin Warren, M.D., an Australian
    pathologist, discovered numerous bacteria living
    in tissue taken during a stomach biopsy.
  • Spiral urease-producing, Gram-negative bacteria
    always accompanied changes in the stomach lining

20
Peptic ulcer disease H. pylori
  • 1982 - Barry Marshall, M.D., joined Dr. Warren in
    his research
  • 1984 - The Lancet, 100 people undergoing
    endoscopy, all 13 people with duodenal ulcers and
    24 of 28 people with gastric ulcers were infected
    with Helicobacter pylori

21
Peptic ulcer disease H. pylori
  • 1984 - Dr. Marshall swallowed a large number of
    the bacteria himself to test his ideas about H.
    pylori
  • For 5 days, he noticed nothing. Then, he began to
    experience nausea and vomiting
  • Symptoms resolved on their own after 14 days, an
    endoscopy on the 8th day revealed that he had
    developed severe gastritis

22
Peptic ulcer disease H. pylori
  • 1988 - Marshall and Warren published a report
    demonstrating the effectiveness of antibiotics in
    the treatment of peptic ulcers
  • Randomly assigned 100 people with duodenal ulcers
    to receive either cimetidine or an antibiotic
    regimen that targeted H. pylori
  • Ulcers returned in 90 of people treated with
    cimetidine
  • Ulcers returned in only 21 of those whose H.
    pylori infection was eliminated with an
    antibiotic and bismuth

23
(No Transcript)
24
PUD Gastric ulcer types
  • Type I lesser curvature
  • Antral gastritis and H. pylori infection often
    present
  • Type II prepyloric
  • Occur in association with duodenal ulcers
  • Type III antrum
  • Result from NSAID use
  • Type IV lesser curvature, near the GE junction
  • Similar pathophysiology to type I

25
PUD Clinical features
  • Patients present with epigastric pain
  • Typically worse in the morning
  • Burning, stabbing, gnawing
  • Commonly relieved by eating or taking antacids
  • Patients may present acutely with bleeding,
    perforation, or obstruction

26
PUD - Diagnosis
  • Barium contrast study or endoscopy

27
PUD H. pylori and diagnosis
  • Serology reliable marker of initial infection
  • Remains even after the eradication of bacteria
  • Urea breath test more reliable marker of active
    infection
  • Labeled urea is converted into ammonia and
    labeled carbon dioxide by the H. pylori urease in
    the stomach
  • Endoscopic biopsy

28
PUD Medical Treatment
29
(No Transcript)
30
Surgical treatment of PUD
  • Indicated for failures of medical treatment and
    in patients presenting with complications
  • Truncal vagotomy with drainage (pyloroplasty,
    antrectomy, or gastrojejunostomy)
  • Proximal gastric vagotomy
  • Highly selective vagotomy

31
  • TV and drainage
  • 1-2 operative mortality
  • TV/antrectomy
  • 1-2 risk of recurrent ulceration
  • 10-15 risk of persistent dumping sxs
  • TV/pyloroplasty
  • 10 risk of recurrent ulceration
  • 1 risk of persistent dumping sxs
  • HSV
  • lt1 operative mortality
  • 1 risk of persistent dumping sxs
  • 10-15 risk of recurrent ulceration

32
Physiological changes after truncal vagotomy
  • Gastric effects
  • Decreased basal acid output
  • Decreased maximal acid output
  • Increased fasting and postprandial gastrin
  • Gastrin cell hyperplasia
  • Accelerated liquid emptying
  • Nongastric effects
  • Decreased pancreatic exocrine secretion
  • Decreased postprandial bile flow
  • Diminished release of vagally mediated peptide
    hormones

33
Gastric surgery complications - Dumping syndrome
  • Delivery of hyperosmotic fluid to the small bowel
    leading to massive fluid shifts
  • Sxs postprandial palpitations, sweating,
    weakness, dyspnea, nausea, cramps, diarrhea,
    syncope
  • Dx hyperosmolar glucose load will elicit sxs
  • Tx multiple small, low-fat, low-carbohydrate
    meals that are high in protein
  • Preprandial octreotide may reduce sxs

34
Gastric surgery complications - Alkaline reflux
gastritis
  • Reflux of bile into stomach following BI, BII, or
    pyloroplasty
  • Sxs Postprandial pain, bilious emesis
  • Dx Endoscopy, HIDA scan
  • Tx Cholestyramine, reglan, acid-suppression
  • Surgical tx conversion to Rou-en-Y
    gastrojejunostomy

35
Gastric surgery complications
36
Perforated peptic ulcer
  • Incidence of perforation is 5-10 of all patients
    with peptic ulcer disease
  • Incidence of perforation has not decreased
    proportional to the overall decline in peptic
    ulcer disease over the past few decades
  • Perforation is often the first clinical
    presentation of the disease

37
Perforated peptic ulcer
  • Mortality of 1-20
  • Accounts for 70 of deaths associated with PUD
  • Negative prognostic factors include presence of
    comorbid conditions, gt 24 hours since time of
    perforation to time of repair, presence of shock

38
Perforated peptic ulcer - Presentation
  • Sudden onset of severe upper abdominal pain
  • May be referred to back or shoulder
  • Boardlike rigidity
  • Mild leukocytosis
  • Mildly elevated serum amylase levels
  • Dx based on upright CXR in 85 of cases
  • Most commonly occurs on anterior gastric or
    duodenal wall

39
Perforated peptic ulcer Treatment options
  • Simple closure
  • Simple closure with overlying omental patch
  • Simple closure with fibrin glue sealing
  • Closure with Graham patch
  • Simple closure with overlying omental patch or
    Graham patch closure with
  • truncal vagotomy
  • proximal gastric vagotomy
  • highly selective vagotomy

40
Timing of acid reduction
  • Patients are selected for an immediate
    acid-reducing procedure after perforation if
  • Perforation less than 24 hours
  • No comorbid conditions
  • No evidence of shock
  • History of sxs gt 3 months
  • In these patients, ulcer recurrence is lt 10 with
    no additional perioperative morbidity or
    mortality

41
Timing of acid reduction
  • If the traditional criteria are met,
    acid-reduction surgery is strongly indicated in
    patients who
  • have previously failed an H. pylori eradication
    regimen
  • are known to be not infected by H. pylori
  • have suffered other complications of PUD
    (including bleeding and/or obstruction)
  • are NSAID dependent

42
Gastric cancer
  • Incidence in U.S. 10/100,000
  • Incidence in Japan 78/100,000
  • 10th most common cancer
  • 5-year survival in U.S. is 12
  • 5-year survival in Japan in 53
  • Overall incidence in U.S. is decreasing

43
Gastric cancer Risk factors
  • Environmental/general dietary nitrites, smoking,
    H. pylori infection, black race, male gender, low
    socioeconomic class
  • Gastric chronic atrophic gastritis,
    hypochlorhydric or achlorhydric state, pernicious
    anemia, adenomatous polyp, previous gastric
    surgery

44
Pathology of gastric cancer
  • 95 of gastric cancers are adenocarcinomas
  • Remaining 5 includes lymphoma, carcinoid, GISTs,
    and squamous cell
  • Macroscopically divided into ulcerative (75),
    polypoid (10), scirrhous (10), and superficial
    (5)
  • Histologically divided into intestinal and
    diffuse
  • Over past few decades, increase in proximally
    occurring tumors

45
Presentation of gastric cancer
  • Vague epigastric discomfort
  • Anorexia
  • Weight loss
  • Vomiting
  • Dysphagia
  • Palpable mass in up to 30 of patients
  • 10 present with evidence of metastatic disease
    (Virchows node, Sister Mary Josephs node,
    Blumers shelf, ascites, jaundice)

46
Surgical treatment of gastric cancer
  • Total gastrectomy with Roux-en-Y reconstruction
  • Advocated for proximal and midbody tumors
  • Subtotal gastrectomy
  • Advocated for distal tumors
  • Entails resection of ¾ of the stomach
  • 5-6 cm resection margin when possible
  • ? Splenectomy
  • Routine splenectomy does not improve survival but
    does increase morbidity and mortality

47
(No Transcript)
48
Lymphadenectomy in gastric cancer
  • Role of extended lymphadenectomy in gastric
    cancer remains controversial
  • Current recommendation is D1 dissection
  • D1 removal of all nodal tissue within 3 cm of
    the primary tumor
  • D2 D1 clearance of hepatic, splenic, celiac,
    and left gastric lymph nodes
  • D3 D2 omentectomy, splenectomy, distal
    pancreatectomy, and clearance of porta hepatis
    lymph nodes

49
Gastric lymphoma
  • Increasing in incidence
  • Accounts for 2/3 of GI lymphoma
  • Average age at presentation is 60
  • Endoscopy permits diagnosis in 90 of patients
  • Most lesions are located in the distal stomach,
    spread locally by submucosal infiltration
  • Initial treatment is chemotherapy doxorubicin
    and cyclophosphamide
  • Surgery reserved for patients with an incomplete
    response or a recurrence

50
Gastroduodenal Crohns
  • Prevalence of 0.5-13 in patients with
    ileocolonic disease
  • UGI involvement is typically in the antrum and
    duodenal bulb
  • Sxs include epigastric pain and dyspepsia
  • Hematemesis and melena are rare

51
Gastroduodenal Crohns
  • Duodenal fistula are rare (0.5)
  • Fistulae involving the stomach almost always
    originate from the colon or small bowel
  • Corticosteroids are the mainstay of medical tx
  • Unknown role of acid reduction therapy

52
Surgery for gastroduodenal Crohns
  • Gastrojejunostomy
  • Most commonly performed surgery for
    gastroduodenal Crohns
  • Indicated for obstruction and fistulization
  • Unknown role for vagotomy
  • Stricturoplasty
  • ?Advantageous compared to gastrojejunostomy given
    less mobilization of small bowel

53
Which of the following statements is/are true
regarding the arterial supply to the stomach
  • A) The right gastric artery, a branch of the SMA
    supplies the gastric antrum
  • B) Gastric viability may be preserved after
    ligation of all but one major artery
  • C) In cases of celiac artery occlusion, gastric
    viability is maintained collaterally through
    pancreaticoduodenal arcades
  • D) The left gastroepiploic artery is a branch of
    the celiac trunk

54
At a cellular level, the major stimulant(s) of
acid secretion by the gastric parietal cell
is/are
  • A) Histamine
  • B) Prostaglandin E2
  • C) Acetylcholine
  • D) Gastrin
  • E) Norepinephrine

55
Which of the following statements is/are correct
regarding intrinsic factor
  • A) Intrinsic factor is produced in chief cells
    located in the gastric fundus
  • B) Total gastrectomy is following by folate
    deficiency caused by vitamin malabsorption due to
    intrinsic factor deficiency
  • C) Secretion of intrinsic factor, like that of
    acid, is stimulated by gastrin, histamine, and
    acetylcholine
  • D) Intrinsic factor deficiency accompanies antral
    gastritis caused by H. pylori infection

56
Gastrin release is increased by which of the
following
  • A) Antral acidification
  • B) Ischemia
  • C) Histamine
  • D) Antral distension
  • E) Trauma

57
Appropriate treatment for a perforated ulcer in a
35-year old male who has been treated for peptic
ulcer disease for the past 7 years and is
hemodynamically stable is
  • A) Nasogastric suction and antibiotics
  • B) Closure of the perforation
  • C) Parietal cell vagotomy and pyloroplasty
  • D) Truncal vagotomy and gastroenterostomy

58
Which of the following statements is/are correct
with regard to pyloric obstruction secondary to
peptic ulceration
  • A) Pyloric obstruction is suggested by
    hypochloremic hyponatremic alkalosis
  • B) Pyloric obstruction is suggested by
    hypochloremic hypokalemic alkalosis
  • C) Approximately 80 of patients with benign
    gastric outlet obstruction obtain permanent
    relief with endoscopic balloon dilatation
  • D) The lifetime risk of pyloric obstruction among
    patients with peptic ulcer is 40

59
50 yo M underwent truncal vagotomy with BII
reconstruction 2 yrs ago. He now has postprandial
pain, nausea, bilious emesis. Endoscopy reveals
bile in the stomach evidence of severe gastritis.
Appropriate therapy would include
  • A) Octreotide administration
  • B) Conversion of BII gastrojejunostomy to BI
    gastroduondenostomy
  • C) Conversion of BII gastrojejunostomy to
    Roux-en-Y gastrojejnostomy
  • D) Roux-en-Y hepaticojejunostomy

60
Which of the following conditions is considered
to increase the risk of gastric cancer
  • A) Pernicious anemia
  • B) Previous partial gastrectomy
  • C) Gastric hyperplastic polyps
  • D) Gastric adenomatous polyps

61
With regard to operative management of gastric
carcinoma, which of the following is/are correct
  • A) Resection margins of 2 cm are necessary to
    prevent recurrence due to intramural metastasis
  • B) Prophylactic splenectomy has been shown to
    improve outcome among similarly staged patients
  • C) Extended lymphadenectomy that includes nodes
    along the aorta and esophagus has not been shown
    to improve survival in North American trials
  • D) Long-term survival is rare if adjacent organs
    must be resected to achieve local control

62
Which of the following statements regarding
gastric lymphoma is/are correct
  • A) More than one-half of GI lymphomas occur in
    the stomach
  • B) The peak incidence of gastric lymphoma is in
    the 2nd and 3rd decades of life
  • C) Endoscopic biopsy provides enough information
    for a diagnosis in 90 of cases
  • D) Gastric perforation occurs among 40 of
    patients treated with cytolytic agents instead of
    gastrectomy
Write a Comment
User Comments (0)
About PowerShow.com